Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats

Journal of Bone and Mineral Research

Volumn 11, Issue 4, 1996, Pages 421-429

  Meng, X W ^a,b   Liang, X G ^a   Birchman, R ^a   Wu, D D ^a   Dempster, D W ^a,c   Lindsay, R ^a,c   Shen, V ^a,c  

^a HELEN HAYES HOSPITAL   (United States)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; ESTROGEN; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; BONE ATROPHY; BONE MINERALIZATION; CANCELLOUS BONE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; HORMONE ACTION; NONHUMAN; OSTEOMETRY; OVARIECTOMY; RAT;

EID: 0029983607     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110402     Document Type: Article

References (33)

1. Christiansen C 1992 Prevention and treatment of osteoporosis: a review of current modalities. Bone 13:535-539.
2. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC 1976 Long term prevention of postmenopausal osteoporosis by estrogen. Lancet 1:1038-1040.
3. Riggs BL, Hodgson SF, O'Fallon WM, Chao EW, Wahner HW, Muhs JM, Cedel SL, Melton III LJ 1990 Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802-809.
4. Kleerekoper M, Peterson EL, Nelson DA, Philips E, Schork MA, Tilley BC, Parfitt AM 1991 A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteo Int 1:155-161.
5. Pak CY, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K 1989 A safe and effective treatment of primary osteoporosis by intermittent application of slow-release sodium fluronde: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 68:150-159.
6. Hesp R, Hulme P, Williams D, Reeve J 1981 The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human PTH fragment 1-34. Metab Bone Dis Rel Res 2:331-334.
7. Reeve J, Arlot M, Bernat M, Charhon S, Edouard C, Slovik D, Vismans FJFE, Meunier PJ 1981 Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH1-34) therapy. Metab Bone Dis Rel Res 3:23-30.
8. Reeve J, Arlot M, Bernat M, Edouard C, Hesp R, Slovik D, Vismans FIFE, Meunier PJ 1980 Treatment of osteoporosis with human PTH fragment 1-34: a positive final tissue balance in trabecular bone. Metab Bone Dis Rel Res (Suppl) 2:355-360.
9. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OLM, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJFE, Potts JT 1980 Anabolic effect of human PTH on trabecular bone in involutional osteoporosis: a multicenter trial. Br Med J 280:1340-1344.
10. Mosekilde L, Danielsen CC, Gasser J 1994 The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human PTH (1-38), and combination therapy, assessed in aged ovariectomized rats. Endocrinol 134:2126-2134.
11. Sogaard CC, Wronski TJ, McOsker JE, Mosekilde L 1994 The positive effect of PTH on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates. Endocrinol 134:650-657.
12. Ejersted C, Andreassen TT, Oxlund H, Jorgensen PH, Bak B, Haggblad J, Torring O, Nilsson MH 1993 Human PTH (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097-1101.
13. Kalu DN 1991 The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-191.
14. Frost HM, Jee WSS 1992 On the rat model of human osteopenias and osteoporosis. Bone Miner 18:227-236.
15. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of PTH on bone. Endocrine Rev 14: 690-709.
16. Gunness M, Hock JM 1993 Anabolic effect of PTH on cancellous and cortical bone histology. Bone 14:277-281.
17. Hock JM, Gera I, Fonseca J, Raisz LG 1989 Resorption is not essential for the stimulation of bone growth by human PTH 1-34 in rats in vivo. J Bone Miner Res 4:449-458.
18. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R 1993 Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with PTH and estradiol. J Clin Invest 91:2479-2487.
19. Wronski TJ, Yen CF, Qi H, Dann LM 1993 Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinol 132:823-831.
20. Jerome CP 1994 Anabolic effect of high doses of human parathyroid hormone (1-38) in mature female rats. J Bone Miner Res 9:933-942.
21. Ma YF, Jee WSS, Ke HZ, Lin BY, Liang XG, Li M, Yamamoto N 1995 Human PTH (1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats. J Bone Min Res 10:496-505.
22. Li M, Mosekilde L, Sogaard CH, Thomsen JS, Wronski TJ 1995 PTH monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats. Bone 16:629-635.
23. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Muenier PJ, Ott SM, Recker RR. 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610.
24. Dempster DW, Shane E, Herbert W, Lindsay R 1986 A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: qualitative observations in normal and osteoporotic subjects. J Bone Miner Res 1:15-21.
25. Hvid I, Andersen K, Diesen S 1984 The osteopenetrometer. Engineering in Med 13:73-78.
26. Hvid I, Hansen SL 1985 Trabecular bone strength patterns at the proximal tibial eptphysis. J Orthopaedia Res 3:464-472.
27. Neer M, Slovik DM, Daly N, Potts Jr JT, Nussbaum SR 1993 Treatment of postmenopausal osteoporosis with daily PTH plus calcitriol. Osteopor Int (Suppl) 1:5204-205.
28. Lindsay R, Cosman F, Nieves J, Dempster DW, Shen V 1993 A controlled clinical trial of the effects of 1-34hPTH in estrogen treated osteoporotic women. J Bone Miner Res 8: (Suppl 1) S130.
29. Tobias JH, Chow JW, Chambers TJ 1993 3-amino-1-hydroxyporpylindine-1-bisphosphonate (AHPrBP) suppresses not only the induction of new, but also, the persistence of existing bone-forming surfaces in rat cancellous bone. Bone 14:619-623.
30. Steiniche T, Christiansen P, Vesterby A, Hasling C, Ullerup R, Mosekilde L, Melsen F1994 Marker changes in iliac crest bone structure in postmenopausal osteoporotic patients without any signs of disturbed bone remodeling or balance. Bone 15:73-79.
31. Weinstein RS, Hutson MS 1987 Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging. Bone 8:137-142.
32. Shen V, Birchman R, Xu R, Otter M, Wu DD, Lindsay R, Dempster DW 1995 Effects of reciprocal treatment with estrogen and estrogen plus PTH on bone structure and strength in Ovx rats. J Clin Invest 96:2331-2338.
33. Qi H, Li M, Wroaski TJ 1995 A comparison of the anabolic effects of PTH at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Min Res 10: 948-955.